questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Isomerases
Intramolecular transferases
Phosphotransferases phosphomutases
Phosphotransferases phosphomutases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Gene Expression Profiling
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phosphotransferases phosphomutases : Questions médicales les plus fréquentes",
"headline": "Phosphotransferases phosphomutases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phosphotransferases phosphomutases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-08",
"dateModified": "2025-03-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phosphotransferases phosphomutases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Intramolecular transferases",
"url": "https://questionsmedicales.fr/mesh/D019751",
"about": {
"@type": "MedicalCondition",
"name": "Intramolecular transferases",
"code": {
"@type": "MedicalCode",
"code": "D019751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.399.520"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bisphosphoglycerate mutase",
"alternateName": "Bisphosphoglycerate Mutase",
"url": "https://questionsmedicales.fr/mesh/D001731",
"about": {
"@type": "MedicalCondition",
"name": "Bisphosphoglycerate mutase",
"code": {
"@type": "MedicalCode",
"code": "D001731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.399.520.750.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosphoglucomutase",
"alternateName": "Phosphoglucomutase",
"url": "https://questionsmedicales.fr/mesh/D010733",
"about": {
"@type": "MedicalCondition",
"name": "Phosphoglucomutase",
"code": {
"@type": "MedicalCode",
"code": "D010733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.399.520.750.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosphoglyceromutase",
"alternateName": "Phosphoglycerate Mutase",
"url": "https://questionsmedicales.fr/mesh/D010736",
"about": {
"@type": "MedicalCondition",
"name": "Phosphoglyceromutase",
"code": {
"@type": "MedicalCode",
"code": "D010736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.399.520.750.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Phosphotransferases phosphomutases",
"alternateName": "Phosphotransferases (Phosphomutases)",
"code": {
"@type": "MedicalCode",
"code": "D017875",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stewart Shuman",
"url": "https://questionsmedicales.fr/author/Stewart%20Shuman",
"affiliation": {
"@type": "Organization",
"name": "Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA shumans@mskcc.org."
}
},
{
"@type": "Person",
"name": "Jean-Marc Jeckelmann",
"url": "https://questionsmedicales.fr/author/Jean-Marc%20Jeckelmann",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry and Molecular Medicine, Medical Faculty, University of Bern, Bern, Switzerland."
}
},
{
"@type": "Person",
"name": "Balraj Doray",
"url": "https://questionsmedicales.fr/author/Balraj%20Doray",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA."
}
},
{
"@type": "Person",
"name": "Benjamin C Jennings",
"url": "https://questionsmedicales.fr/author/Benjamin%20C%20Jennings",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA."
}
},
{
"@type": "Person",
"name": "Wang-Sik Lee",
"url": "https://questionsmedicales.fr/author/Wang-Sik%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gene expression profile analyses to identify potential biomarkers for myopia.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35610360",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02013-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Population-Specific gene expression profiles in prostate cancer: insights from Weighted Gene Co-expression Network Analysis (WGCNA).",
"datePublished": "2024-07-05",
"url": "https://questionsmedicales.fr/article/38970097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-024-03459-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of potential crucial genes and mechanisms associated with metastasis of medulloblastoma based on gene expression profile.",
"datePublished": "2022-10-10",
"url": "https://questionsmedicales.fr/article/36215435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01616412.2022.2132457"
}
},
{
"@type": "ScholarlyArticle",
"name": "RoPE: A robust profile likelihood method for differential gene expression analysis.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37042632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/gepi.22526"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive identification of GASA genes in sunflower and expression profiling in response to drought.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39402437",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12864-024-10860-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Isomerases",
"item": "https://questionsmedicales.fr/mesh/D007535"
},
{
"@type": "ListItem",
"position": 5,
"name": "Intramolecular transferases",
"item": "https://questionsmedicales.fr/mesh/D019751"
},
{
"@type": "ListItem",
"position": 6,
"name": "Phosphotransferases phosphomutases",
"item": "https://questionsmedicales.fr/mesh/D017875"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phosphotransferases phosphomutases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phosphotransferases phosphomutases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phosphotransferases phosphomutases",
"description": "Comment diagnostiquer une déficience en phosphomutases ?\nQuels tests sont utilisés pour évaluer l'activité des phosphomutases ?\nQuels symptômes peuvent indiquer un problème avec les phosphomutases ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle imagerie peut aider à diagnostiquer des troubles liés aux phosphomutases ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phosphotransferases phosphomutases",
"description": "Quels sont les symptômes d'une déficience en phosphomutases ?\nLes douleurs musculaires sont-elles liées aux phosphomutases ?\nPeut-on observer des anomalies métaboliques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cliniques spécifiques à surveiller ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phosphotransferases phosphomutases",
"description": "Peut-on prévenir les troubles liés aux phosphomutases ?\nY a-t-il des conseils diététiques pour prévenir les symptômes ?\nLes tests de dépistage sont-ils recommandés ?\nComment le suivi médical aide-t-il à la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phosphotransferases phosphomutases",
"description": "Quels traitements sont disponibles pour les troubles liés aux phosphomutases ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nY a-t-il des traitements expérimentaux en cours ?\nComment la nutrition influence-t-elle le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phosphotransferases phosphomutases",
"description": "Quelles complications peuvent survenir avec une déficience en phosphomutases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phosphotransferases phosphomutases",
"description": "Quels sont les facteurs de risque pour les troubles des phosphomutases ?\nL'environnement joue-t-il un rôle dans ces troubles ?\nLes habitudes alimentaires influencent-elles le risque ?\nY a-t-il des groupes à risque spécifique ?\nLe stress peut-il affecter le risque de troubles ?",
"url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Gene+Expression+Profiling&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en phosphomutases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des phosphomutases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'activité enzymatique in vitro mesurent la fonction des phosphomutases."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec les phosphomutases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, fatigue et douleurs musculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations spécifiques liées aux phosphomutases."
}
},
{
"@type": "Question",
"name": "Quelle imagerie peut aider à diagnostiquer des troubles liés aux phosphomutases ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique (IRM) peut être utilisée pour évaluer les tissus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en phosphomutases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles de la croissance."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires sont-elles liées aux phosphomutases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent survenir en raison de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Peut-on observer des anomalies métaboliques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans le métabolisme des glucides et des lipides peuvent être présentes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques spécifiques à surveiller ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'hypoglycémie et des troubles neurologiques peuvent être observés."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux phosphomutases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques pour prévenir les symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en nutriments peut aider à prévenir certains symptômes."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage peuvent être recommandés pour les familles à risque."
}
},
{
"@type": "Question",
"name": "Comment le suivi médical aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier permet de surveiller les symptômes et d'ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas directement les troubles enzymatiques, mais aident à la santé générale."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux phosphomutases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour traiter certaines déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour gérer les symptômes associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux en cours ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs études cliniques explorent de nouveaux traitements pour ces troubles."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut améliorer la gestion des symptômes et le métabolisme."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en phosphomutases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de complications à long terme existent, nécessitant un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des phosphomutases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans ces troubles ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent influencer l'expression des gènes liés aux phosphomutases."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise alimentation peut exacerber les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque spécifique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec des antécédents familiaux de troubles métaboliques sont à risque accru."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le risque de troubles ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes et influencer le métabolisme."
}
}
]
}
]
}
Increasing evidence suggests myopia is not a simple refractive error, many other factors might also be involved. Here, we assessed myopic and normal corneas' gene expression profiles to identify possi...
We obtained the expression profile of ten patients and seven normal control samples from the GSE112155 and GSE151631 datasets based on the Gene Expression Omnibus (GEO) database. We used the "limma" R...
We identified that the DEGs were significantly enriched in ultraviolet (UV) response, TNF-α signaling via NFκB, Angiogenesis, Myogenesis pathways, etc. We used 2095 genes to construct the co-expressio...
Our findings identified some markers that might detect diagnosis and treatment for myopia from cornea aspect. Future studies are warranted to verify the functional role of immune-related pathways in c...
This study investigates the genetic factors contributing to the disparity in prostate cancer incidence and progression among African American men (AAM) compared to European American men (EAM). The res...
Medulloblastoma is the most common malignant brain tumor in childhood. Although metastasis constitutes one of the poorest prognostic indicators in this disease, the mechanisms that drive metastasis ha...
Gene expression profile of GSE468 was downloaded from GEO database and was analyzed using limma R package. Function and enrichment analyses of DEGs were performed based on PANTHER database. PPI networ...
Nine upregulated genes and 34 downregulated genes were selected as DEGs. The upregulated genes were mainly enriched in molecular function and cell component, which mainly included protein binding and ...
Through the bioinformatics analysis of the gene microarray in GEO, we found some crucial genes and pathways associated with the metastasis of medulloblastoma....
Variation in RNA-Seq data creates modeling challenges for differential gene expression (DE) analysis. Statistical approaches address conventional small sample sizes and implement empirical Bayes or no...
Drought stress poses a critical threat to global crop yields and sustainable agriculture. The GASA genes are recognized for their pivotal role in stress tolerance and plant growth, but little is known...
In this study we examine the impact of cell confluency on gene expression. We focused on Argonaute (AGO) protein dynamics and associated gene and protein expression in HEK293, A375, and SHSY5Y cell li...
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and has a poor prognosis. Identifying biomarkers based on molecular mechanisms is critical for early diagnosis, timely treatme...
MALAT1 expression levels were measured using RT-qPCR. The biological functions of MALAT1 in NSCLC were analyzed by cell counting, colony forming, wound-healing, and Transwell invasion assays. In addit...
Comparative analysis versus MALAT1 expression in MRC5 cells (a normal lung cell line) and the three NSCLC cell lines showed that MALAT1 expression was significantly higher in the NSCLC cells. MALAT1 k...
MALAT1 might function as an oncogene that enhances NSCLC cell survival, proliferation, colony formation, and invasion. RNA-seq and bioinformatic analyses resulted in the selection of five DEGs, PGAM1,...
Liver cirrhosis has been increasingly diagnosed at an early stage owing to the non-invasive diagnostic techniques. However, it is difficult to identify patients at high risk of disease progression. Sc...
RNA-sequencing (RNA-seq) is a versatile, high-throughput technology that is being widely employed for screening differentially expressed genes (DEGs) in various diseases. Echinococcosis, a globally di...
Sertoli cell-only syndrome (SCOS) is the most severe and common pathological type of non-obstructive azoospermia. The etiology of SCOS remains largely unknown to date despite a handful of studies repo...